Data Handling Platform Achieves High Standards

Big data tech company Aigenpulse, specialists in structuring, integrating and deriving meaning from large, disparate data assets, has achieved certification to the internationally recognised standards ISO 9001:2015 and ISO 27001:2013.

The ISO accreditation adds strength to the company’s platform offering, which deploys artificial intelligence (AI) and advanced machine learning technologies to help researchers to unlock the power of their data, ultimately increasing the efficiency at which new and improved drugs reach patients. Scientists use the platform to structure, share and analyse their research, translational and preclinical data. This makes it easier to search and visualise relationships in the large and diverse data sets generated by R&D pipelines. Analyses can be automated, enabling researchers to focus on core science, while benefitting from data to augment experience and intuition in decision making.

Dr. Tobias Kloepper, CEO at Aigenpulse, said: “We are extremely proud of gaining certification to both ISO 9001 and ISO 27001 standards in such a short amount of time – for a company less than three years old, this is a great achievement. These certifications underline our commitment to customers and our focus on quality, data security and reliability.

“As part of implementing a Quality Management System we have automated all of our compliance processes which have been designed to drive high quality performance and continuous improvement. We are now even better placed to respond to customer needs quickly and efficiently.

“Customers, stakeholders and staff can be reassured that their information is being held and managed securely and that as a management team we take our accountability for protecting our systems and client data very seriously.

Last October the company moved into larger premises in Oxford at Milton Park and opened offices at the CIC in Boston, Massachusetts. The additional spaces support the company’s continued expansion, growing four-fold in the last year, including the appointment of Nick Cross as Non-Executive Director, and Dr Satnam Surae as Chief Product Officer.